At WISE Genomics, we are pioneering the future of women’s healthcare through cutting-edge genomic research and innovation. Based in Montreal, Canada, our mission is to transform cancer detection by developing advanced genetic screening tests that identify women’s cancers—endometrial and ovarian—at their earliest stages and identify women who don’t have a cancer yet but are at a higher risk to develop endometrial, ovarian, breast, colon, and pancreatic cancer due to a hereditary predisposition.
 
Early detection is critical in the fight against cancer, significantly improving treatment success rates, survivability, and quality of life. Our proprietary genetic testing technology harnesses the power of genomics, precision medicine, and molecular diagnostics to provide more accurate, non-invasive, and early detection solutions for women worldwide.
 
By identifying cancer-related genetic markers before symptoms appear, we empower both patients and healthcare providers with the tools needed for personalized treatment strategies and proactive healthcare decisions.
 
At WISE Genomics, we are dedicated to advancing women’s health research and innovation. Through our breakthrough screening solutions, we strive to set a new standard in cancer prevention, genetic testing, and personalized medicine—helping women live longer, healthier lives.
 
Join us in transforming the future of cancer detection with next-generation genomic screening technology.

WISE Genomics

Org chart

Teams

Offices